Skip to main content

Some PCOS Therapies Cut Cardiovascular Risk : Data on cardiometabolic risk in PCOS treatment show cyproterone acetate to be a 'bad actor.'

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Some PCOS Therapies Cut Cardiovascular Risk : Data on cardiometabolic risk in PCOS treatment show cyproterone acetate to be a 'bad actor.'

User login

Username

Password

Reset your password

Type	Lead	score